NeuroOne Medical Technologies
NMTC
20 hedge funds and large institutions have $867K invested in NeuroOne Medical Technologies in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
82% more funds holding
Funds holding: 11 → 20 (+9)
26% more capital invested
Capital invested by funds: $686K → $867K (+$181K)
0.32% more ownership
Funds ownership: 0.42% → 0.74% (+0.32%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$128K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$53.8K |
| 3 |
VF
Virtu Financial
New York
|
+$22.3K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$6.79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCG
Newport Capital Group
Red Bank,
New Jersey
|
-$24K |
| 2 |
DWM
Drive Wealth Management
Lehi,
Utah
|
-$3.67K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.01K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$465 |
NMTC Hedge Fund Activity: Q4 2022 in Review
20 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q4 2022, worth a combined $867K — up 26% from $686K a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new NMTC positions and 2 closed out — a net gain of 9 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $128K. The largest seller was Newport Capital Group, exiting entirely with an estimated $24K sold.
- 20 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q4 2022, up from 11 in Q3 2022.
- Funds reported $867K of NeuroOne Medical Technologies stock for Q4 2022, up 26% quarter-over-quarter.
- 11 funds opened new NeuroOne Medical Technologies positions in Q4 2022 and 2 closed out, a net change of +9 holders.
- The largest NeuroOne Medical Technologies buyer in Q4 2022 was Susquehanna International Group, an estimated $128K added.
- The largest NeuroOne Medical Technologies seller in Q4 2022 was Newport Capital Group, an estimated $24K sold.
Based on aggregated 13F filings for Q4 2022.